HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seung-Mo Hong Selected Research

Epithelioid Hemangioendothelioma

3/2021Prognosis of hepatic epithelioid hemangioendothelioma after living donor liver transplantation.
12/2016Clinicopathological Features and Prognosis of Hepatic Epithelioid Hemangioendothelioma After Liver Resection and Transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seung-Mo Hong Research Topics

Disease

102Neoplasms (Cancer)
09/2022 - 07/2005
37Adenocarcinoma
09/2022 - 07/2006
33Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 02/2009
24Carcinoma (Carcinomatosis)
01/2022 - 07/2005
15Neuroendocrine Tumors (Neuroendocrine Tumor)
05/2022 - 10/2013
9Carcinogenesis
11/2021 - 10/2006
8Cholangiocarcinoma
06/2020 - 11/2012
8Hepatocellular Carcinoma (Hepatoma)
01/2020 - 12/2014
8Neoplasm Metastasis (Metastasis)
01/2018 - 06/2010
6Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 04/2016
6Rectal Neoplasms (Rectal Cancer)
03/2022 - 10/2012
6Lymphatic Metastasis
11/2020 - 08/2010
5Neoplasms, Cystic, Mucinous, and Serous
07/2022 - 10/2011
4Gallbladder Neoplasms (Gallbladder Cancer)
12/2021 - 05/2008
4Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2021 - 10/2019
3Pancreatic Cyst
01/2022 - 01/2011
3Cysts
01/2022 - 01/2014
3Colonic Neoplasms (Colon Cancer)
11/2021 - 01/2014
3Microsatellite Instability
01/2021 - 03/2017
3Margins of Excision
11/2020 - 01/2017
3Parkinson Disease (Parkinson's Disease)
01/2019 - 02/2016
3Primitive Neuroectodermal Tumors (PNET)
09/2018 - 02/2016
3Fibrosis (Cirrhosis)
01/2017 - 02/2012
2Ovarian Neoplasms (Ovarian Cancer)
07/2022 - 01/2022
2Epithelioid Hemangioendothelioma
03/2021 - 12/2016
2Disease Progression
06/2020 - 05/2018
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
06/2019 - 02/2013
2Virus Diseases (Viral Diseases)
02/2019 - 12/2018
2Autoimmune Pancreatitis
08/2017 - 05/2015
2Ulcerative Colitis
08/2017 - 12/2013
2Breast Neoplasms (Breast Cancer)
06/2013 - 11/2012
1Esophageal Squamous Cell Carcinoma
04/2022
1progressive familial intrahepatic 1 Cholestasis
02/2022

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2005
22Biomarkers (Surrogate Marker)IBA
05/2022 - 05/2008
10Indicators and Reagents (Reagents)IBA
06/2022 - 06/2008
7MucinsIBA
07/2022 - 01/2013
7GemcitabineFDA Link
01/2021 - 08/2010
7DNA (Deoxyribonucleic Acid)IBA
07/2017 - 09/2008
6ParaffinIBA
03/2020 - 01/2014
6Formaldehyde (Formol)FDA Link
03/2020 - 01/2014
6Cadherins (E-Cadherin)IBA
01/2020 - 07/2010
5ChromatinIBA
06/2020 - 01/2012
5MicroRNAs (MicroRNA)IBA
02/2012 - 02/2009
4Messenger RNA (mRNA)IBA
09/2019 - 10/2006
4Biological ProductsIBA
12/2015 - 10/2006
3SynaptophysinIBA
04/2022 - 07/2005
3Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 01/2020
3Hematoxylin (Haematoxylon)IBA
01/2022 - 01/2020
3dibenzyldithiocarbamate (DBDC)IBA
01/2022 - 01/2019
3CateninsIBA
02/2021 - 01/2011
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 10/2017
3Peptides (Polypeptides)IBA
10/2020 - 07/2017
3Bile Pigments (Bilin)IBA
09/2020 - 06/2007
3DesminIBA
01/2020 - 01/2015
3AntigensIBA
12/2018 - 01/2017
3ErbB Receptors (EGF Receptor)IBA
04/2016 - 08/2004
3MethyltransferasesIBA
05/2014 - 02/2010
3DecitabineFDA Link
01/2012 - 02/2010
2Ethanol (Ethyl Alcohol)IBA
01/2022 - 09/2018
2Somatostatin Receptors (Somatostatin Receptor)IBA
12/2021 - 02/2016
2folfirinoxIBA
02/2021 - 01/2018
2EnzymesIBA
01/2021 - 08/2015
2Fluorouracil (Carac)FDA LinkGeneric
10/2020 - 01/2017
2lanreotide (Somatuline)FDA Link
06/2020 - 01/2019
2AntibodiesIBA
01/2020 - 01/2020
2Keratin-19 (Keratin 19)IBA
01/2020 - 01/2015
2ChromograninsIBA
10/2019 - 07/2005
2Calcibiotic Root Canal SealerIBA
05/2019 - 01/2015
2alpha-SynucleinIBA
01/2019 - 02/2016
2SynucleinsIBA
01/2019 - 07/2018
2CytokinesIBA
12/2018 - 08/2017
2VimentinIBA
05/2018 - 01/2015
2Phosphotransferases (Kinase)IBA
12/2017 - 06/2010
2Cell Adhesion MoleculesIBA
05/2017 - 01/2011
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2017 - 10/2011
2Circulating Tumor DNAIBA
01/2017 - 02/2014
2Phenobarbital (Luminal)FDA Link
01/2015 - 02/2012
2CarcinogensIBA
08/2014 - 11/2012
2Histone Deacetylase InhibitorsIBA
05/2014 - 07/2011
2CurcuminIBA
11/2012 - 08/2010
1N-acetyltalosaminuronic acid (NAT)IBA
09/2022
1Combined Antibody TherapeuticsIBA
04/2022
1Immune Checkpoint InhibitorsIBA
04/2022
1Therapeutic UsesIBA
01/2022

Therapy/Procedure

18Therapeutics
01/2022 - 05/2008
10Drug Therapy (Chemotherapy)
11/2021 - 08/2015
6Chemoradiotherapy
03/2022 - 10/2012
5Radiotherapy
10/2020 - 08/2010
4Liver Transplantation
02/2022 - 01/2017
4Immunotherapy
06/2021 - 01/2020
4Pancreaticoduodenectomy
01/2019 - 09/2011
3Neoadjuvant Therapy
09/2022 - 10/2020
3Adjuvant Chemotherapy
06/2022 - 01/2017
3Pancreatectomy
03/2019 - 02/2012
2Gastrectomy
01/2022 - 12/2021
2Hepatectomy
03/2021 - 12/2016
2Lasers (Laser)
01/2020 - 02/2012
2Operative Surgical Procedures
02/2016 - 10/2012
1Salpingo-oophorectomy
07/2022